跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,772 条关于
“Sandoz Australia”
全部
2,772
临床试验
433
药物
118
机构
527
资讯
1,694
去年
Global Biosimilars Market Set to Triple to $114 Billion by 2031, Driven by Patent Expirations and Cost Advantages
7个月前
Alvotech Partners with Sandoz to Expand Biosimilar Access Across Canada, Australia, and New Zealand
去年
Sandoz Resolves Patent Dispute with Regeneron, Clearing Path for Eylea Biosimilar Launch by 2026
去年
Lupin Partners with Sandoz to Commercialize Ranibizumab Biosimilar Across Multiple Global Markets
去年
Australian Court Denies Preliminary Injunction Against Sandoz Aflibercept Biosimilar Launch
去年
Avecho and Sandoz Partner in Landmark $19M Deal to Develop OTC CBD Insomnia Treatment
昨天
Sandoz Licenses Emicizumab Biosimilar From mAbxience, Adding First Haemophilia Asset to 40-Drug Pipeline
去年
European Commission Approves Sandoz's Afqlir, an Aflibercept Biosimilar, for Retinal Diseases
去年
Henlius and Sandoz Partner on Ipilimumab Biosimilar in $301 Million Deal to Expand Global Access
去年
European Commission Approves Sandoz's Aflibercept Biosimilar, Afqlir, for Retinal Diseases
第 1 页,共 170 页
上一页
下一页